Palisade Bio Inc.(PALI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PALI Palisade Bio Inc.

交易中 02-27 10:56:40 EST

1.83

-0.02

-1.35%

最高1.85	最低1.80	成交量47.83万
今开1.81	昨收1.85	日振幅2.70%
总市值2.72亿	流通市值1.92亿	总股本1.49亿
成交额87.21万	换手率0.46%	流通股本1.05亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PALI","market":"US","secType":"STK","nameCN":"Palisade Bio Inc.","latestPrice":1.825,"timestamp":1772207791633,"preClose":1.85,"halted":0,"volume":478277,"delay":0,"changeRate":-0.013513513513513585,"floatShares":105000000,"shares":149000000,"eps":-2.330592,"marketStatus":"交易中","change":-0.025,"latestTime":"02-27 10:56:40 EST","open":1.81,"high":1.8499,"low":1.8,"amount":872081.672814,"amplitude":0.026973,"askPrice":1.83,"askSize":5054,"bidPrice":1.82,"bidSize":2614,"shortable":3,"etf":0,"ttmEps":-2.330592,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772226000000},"marketStatusCode":2,"adr":0,"listingDate":1188187200000,"exchange":"NASDAQ","adjPreClose":1.85,"preHourTrading":{"tag":"盘前","latestPrice":1.8,"preClose":1.85,"latestTime":"09:28 EST","volume":13685,"amount":24903.015998000003,"timestamp":1772202532517,"change":-0.05,"changeRate":-0.027027,"amplitude":0.043081},"postHourTrading":{"tag":"盘后","latestPrice":1.857,"preClose":1.85,"latestTime":"19:56 EST","volume":26418,"amount":48885.6785,"timestamp":1772153819451,"change":0.007,"changeRate":0.003784,"amplitude":0.005405},"volumeRatio":0.628839},"requestUrl":"/m/hq/s/PALI","defaultTab":"news","newsList":[{"id":"2614070727","title":"Palisade Bio, Inc.盘中异动 大幅上涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614070727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614070727?lang=zh_cn&edition=full","pubTime":"2026-02-24 22:45","pubTimestamp":1771944352,"startTime":"0","endTime":"0","summary":"北京时间2026年02月24日22时45分，Palisade Bio, Inc.股票出现异动，股价急速上涨5.59%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。其相关个股中，Larimar Therapeutics, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Palvella Therapeutics, Inc.涨幅较大，Cardio Diagnostics Holdings Inc.、Biorestorative Therapies, Inc.、Silo Pharma, Inc.较为活跃，换手率分别为298.84%、210.56%、171.88%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Klotho Neurosciences, Inc.、Biorestorative Therapies, Inc.，振幅分别为32.69%、28.54%、24.61%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224224552a71a5c72&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224224552a71a5c72&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PALI","BK4139"],"gpt_icon":0},{"id":"2609302262","title":"Palisade Bio, Inc.盘中异动 早盘股价大跌5.12%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2609302262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609302262?lang=zh_cn&edition=full","pubTime":"2026-02-05 00:18","pubTimestamp":1770221898,"startTime":"0","endTime":"0","summary":"北京时间2026年02月05日00时18分，Palisade Bio, Inc.股票出现波动，股价急速跳水5.12%。截至发稿，该股报1.58美元/股，成交量44.9678万股，换手率0.30%，振幅4.52%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020500181897a4e4dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020500181897a4e4dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2608899089","title":"Palisade Bio, Inc.盘中异动 股价大涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608899089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608899089?lang=zh_cn&edition=full","pubTime":"2026-02-02 22:30","pubTimestamp":1770042646,"startTime":"0","endTime":"0","summary":"北京时间2026年02月02日22时30分，Palisade Bio, Inc.股票出现波动，股价急速上涨5.37%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Polyrizon Ltd.、Molecular Partners Ag涨幅较大，60 Degrees Pharmaceuticals, Inc.、Vivosim Labs, Inc.、Vyome Holdings, Inc.较为活跃，换手率分别为246.71%、14.91%、14.85%，振幅较大的相关个股有Context Therapeutics Inc.、Plus Therapeutics, Inc.、Palisade Bio, Inc.，振幅分别为14.18%、6.80%、6.04%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020222304797a485f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020222304797a485f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2607779817","title":"Palisade Bio, Inc.盘中异动 急速跳水5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607779817","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607779817?lang=zh_cn&edition=full","pubTime":"2026-01-28 23:37","pubTimestamp":1769614675,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日23时37分，Palisade Bio, Inc.股票出现波动，股价大幅跳水5.52%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.93%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Liminatus Pharma Inc C/Wts 30/04/2030 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Gri Bio, Inc.、Calcimedica, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2122.49%、160.51%、124.01%，振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Gri Bio, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 ，振幅分别为90.64%、36.65%、32.00%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128233755953ec79f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128233755953ec79f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2605310087","title":"Palisade Bio, Inc.盘中异动 早盘快速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605310087","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605310087?lang=zh_cn&edition=full","pubTime":"2026-01-20 22:36","pubTimestamp":1768919796,"startTime":"0","endTime":"0","summary":"北京时间2026年01月20日22时36分，Palisade Bio, Inc.股票出现波动，股价快速拉升5.42%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.34%。其相关个股中，Corvus Pharmaceuticals, Inc.、Rapt Therapeutics, Inc.、Aclaris Therapeutics, Inc.涨幅较大，Jaguar Health, Inc.、Dermata Therapeutics, Inc.、Rapt Therapeutics, Inc.较为活跃，换手率分别为63.06%、46.38%、45.59%，振幅较大的相关个股有Corvus Pharmaceuticals, Inc.、Immunitybio, Inc.、Cytomed Therapeutics Limited，振幅分别为20.62%、15.04%、14.86%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223638a7310a8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120223638a7310a8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"1154866897","title":"Palisade Bio公司两篇摘要获选全球顶尖炎症性肠病大会海报展示","url":"https://stock-news.laohu8.com/highlight/detail?id=1154866897","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154866897?lang=zh_cn&edition=full","pubTime":"2026-01-16 21:32","pubTimestamp":1768570341,"startTime":"0","endTime":"0","summary":"Palisade Bio公司宣布，其提交的两篇研究摘要已获选将在全球领先的炎症性肠病学术会议上进行海报展示。这一进展标志着公司在炎症性肠病领域的研究成果获得国际学术界的认可。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PALI","BK4007"],"gpt_icon":0},{"id":"2602767392","title":"Palisade Bio, Inc.盘中异动 早盘快速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2602767392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602767392?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:46","pubTimestamp":1767883597,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日22时46分，Palisade Bio, Inc.股票出现波动，股价快速下跌5.12%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Enliven Therapeutics, Inc.、Moonlake Immunotherapeutics、Century Therapeutics, Inc.涨幅较大，Pmgc Holdings Inc.、Acrivon Therapeutics, Inc.、Gri Bio, Inc.较为活跃，换手率分别为423.12%、93.18%、54.68%，振幅较大的相关个股有Enliven Therapeutics, Inc.、Acrivon Therapeutics, Inc.、Moonlake Immunotherapeutics，振幅分别为59.43%、28.47%、23.74%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108224637953c3b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108224637953c3b13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"1143360448","title":"Palisade Bio通过任命James Izanec, Md, Agaf为临床开发副总裁加强临床领导团队","url":"https://stock-news.laohu8.com/highlight/detail?id=1143360448","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143360448?lang=zh_cn&edition=full","pubTime":"2025-12-02 21:46","pubTimestamp":1764683215,"startTime":"0","endTime":"0","summary":"Palisade Bio通过任命James Izanec, Md, Agaf为临床开发副总裁加强临床领导团队。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2585975021","title":"Palisade Bio, Inc.盘中异动 急速拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585975021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585975021?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:37","pubTimestamp":1763649451,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时37分，Palisade Bio, Inc.股票出现波动，股价快速拉升5.07%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.28%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Design Therapeutics, Inc.、Annexon, Inc.涨幅较大，Psyence Biomedical Ltd.、Clearmind Medicine Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为936.27%、26.68%、11.93%，振幅较大的相关个股有Seres Therapeutics, Inc.、Biorestorative Therapies, Inc.、康乃德生物，振幅分别为20.15%、16.78%、11.11%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223732a4af7ce9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251120223732a4af7ce9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2584747036","title":"Palisade Bio, Inc.盘中异动 急速上涨5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584747036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584747036?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:53","pubTimestamp":1763391231,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日22时53分，Palisade Bio, Inc.股票出现波动，股价急速上涨5.14%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Zymeworks Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Repare Therapeutics Inc.涨幅较大，Galmed Pharmaceuticals Ltd.、Clearmind Medicine Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为1117.19%、146.19%、49.85%，振幅较大的相关个股有Galmed Pharmaceuticals Ltd.、Invivyd, Inc.、Annovis Bio, Inc.，振幅分别为38.45%、31.06%、27.53%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117225351950a21f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117225351950a21f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"1151912518","title":"Palisade Bio宣布在Fscd治疗的Pali-2108口服首创Pde4抑制剂的1B阶段研究中首批患者接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1151912518","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151912518?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:46","pubTimestamp":1760964386,"startTime":"0","endTime":"0","summary":"Palisade Bio宣布在Fscd治疗的Pali-2108口服首创Pde4抑制剂的1B阶段研究中首批患者接受治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","PALI"],"gpt_icon":0},{"id":"2576465039","title":"Palisade Bio, Inc.盘中异动 股价大涨5.10%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576465039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576465039?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:32","pubTimestamp":1760621521,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时32分，Palisade Bio, Inc.股票出现波动，股价大幅上涨5.10%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。加拿大知识产权局  的此项专利批准为 Palisade Bio 在加拿大的这一创新提供了独占权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213201a6bd1f80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016213201a6bd1f80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"2573867605","title":"Palisade Bio, Inc.股价上涨21.25% 市值涨384.18万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2573867605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573867605?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:31","pubTimestamp":1759757470,"startTime":"0","endTime":"0","summary":"北京时间2025年10月06日21时31分，Palisade Bio, Inc.股票出现异动，股价大幅拉升21.25%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Spruce Biosciences, Inc.、Palisade Bio, Inc.、Leap Therapeutics, Inc.较为活跃，换手率分别为1809.08%、62.08%、19.47%，振幅较大的相关个股有Spruce Biosciences, Inc.、Leap Therapeutics, Inc.、Osr Holdings, Inc.，振幅分别为53.97%、9.52%、8.85%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213110a45529fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251006213110a45529fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SPRB","BK4139","PALI","BK4007"],"gpt_icon":0},{"id":"1181848415","title":"Palisade Bio Inc. - Pali-2108展现良好安全性，无严重不良事件、实验室异常或心电图问题","url":"https://stock-news.laohu8.com/highlight/detail?id=1181848415","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181848415?lang=zh_cn&edition=full","pubTime":"2025-09-17 21:02","pubTimestamp":1758114135,"startTime":"0","endTime":"0","summary":"Palisade Bio Inc.宣布，其药物Pali-2108在临床试验中展现出良好的安全性特征，未出现任何严重不良事件、实验室检查异常或心电图相关问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PALI","BK4139","BK4007"],"gpt_icon":0},{"id":"2567417417","title":"Palisade Bio, Inc.盘中异动 股价大跌5.67%报0.564美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2567417417","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567417417?lang=zh_cn&edition=full","pubTime":"2025-09-16 02:46","pubTimestamp":1757961997,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日02时46分，Palisade Bio, Inc.股票出现异动，股价大幅跳水5.67%。截至发稿，该股报0.564美元/股，成交量21.0643万股，换手率2.26%，振幅8.88%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916024638952f9a2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916024638952f9a2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PALI","BK4007","BK4139"],"gpt_icon":0},{"id":"1197685577","title":"Palisade Bio获得加拿大卫生部批准，启动Pali-2108治疗纤维狭窄性克罗恩病的1B期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1197685577","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197685577?lang=zh_cn&edition=full","pubTime":"2025-09-05 20:45","pubTimestamp":1757076338,"startTime":"0","endTime":"0","summary":"Palisade Bio公司宣布，已获得加拿大卫生部的批准许可，将开展其候选药物Pali-2108针对纤维狭窄性克罗恩病(FSCD)的1B期临床试验。这一监管里程碑的达成，为该公司推进这一创新疗法的临床开发奠定了重要基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2517113926","title":"Palisade Bio, Inc.盘中异动 股价大涨6.28%报0.849美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517113926","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517113926?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:23","pubTimestamp":1741206206,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时23分，Palisade Bio, Inc.股票出现异动，股价快速拉升6.28%。截至发稿，该股报0.849美元/股，成交量3.8325万股，换手率1.29%，振幅6.13%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.84%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042327963b288a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306042327963b288a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"gpt_icon":0},{"id":"2514274386","title":"Palisade Bio, Inc.盘中异动 急速下挫5.40%报0.825美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514274386","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514274386?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:04","pubTimestamp":1740668647,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时04分，Palisade Bio, Inc.股票出现波动，股价大幅下挫5.40%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.74%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Pds Biotechnology Corporation、Quoin Pharmaceuticals Ltd涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为570.34%、101.24%、99.13%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Biorestorative Therapies, Inc.、Quoin Pharmaceuticals Ltd，振幅分别为78.88%、30.36%、25.05%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230407abdf7767&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227230407abdf7767&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PALI","BK4139"],"gpt_icon":0},{"id":"2514850184","title":"Palisade Bio, Inc.盘中异动 股价大跌7.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514850184","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514850184?lang=zh_cn&edition=full","pubTime":"2025-02-27 00:36","pubTimestamp":1740587783,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日00时36分，Palisade Bio, Inc.股票出现异动，股价大幅下跌7.29%。Palisade Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Enveric Biosciences, Inc.、Pds Biotechnology Corporation、Renovaro Inc.涨幅较大，Enveric Biosciences, Inc.、Organovo Holdings, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为5898.28%、215.29%、213.57%，振幅较大的相关个股有Enveric Biosciences, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Organovo Holdings, Inc.，振幅分别为181.36%、49.18%、43.31%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003623a25513f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227003623a25513f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PALI","BK4139"],"gpt_icon":0},{"id":"2514639016","title":"Palisade Bio, Inc.盘中异动 早盘大幅下跌5.09%报0.898美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514639016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514639016?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:37","pubTimestamp":1740497821,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时37分，Palisade Bio, Inc.股票出现波动，股价快速下跌5.09%。截至发稿，该股报0.898美元/股，成交量2.9221万股，换手率0.99%，振幅7.40%。Palisade Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.86%。Palisade Bio, Inc.公司简介：Palisade Bio Inc 是一家临床阶段的生物制药公司，专注于识别和开发保护肠道屏障完整性的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252337019630016c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502252337019630016c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","PALI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.palisadebio.com","stockEarnings":[{"period":"1week","weight":0.135},{"period":"1month","weight":0.0221},{"period":"3month","weight":-0.1232},{"period":"6month","weight":1.7375},{"period":"1year","weight":1.1213},{"period":"ytd","weight":-0.2128}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":-0.0089},{"period":"3month","weight":0.0086},{"period":"6month","weight":0.0686},{"period":"1year","weight":0.1594},{"period":"ytd","weight":0.0108}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Palisade Bio, Inc.成立于1997年，是一家生物制药公司，致力于利用其独有的人类神经干细胞技术为中枢神经系统疾病提供治疗方案。该公司将使这一技术商业化从而使其成为一个发现下一代小分子药物的工具，并且创建一种生物细胞疗法来治疗中枢神经系统疾病。目前公司在马里兰州的罗克维尔市有实验室和办公中心，在圣迭戈和中国也有实验设备。Neuralstem，Inc.开发并维护了一系列专利和专利申请，这些专利和专利申请构成了其研发工作的专有基础。该公司在再生医学领域拥有或独家许可三十（30）项美国和外国授权专利和四十二（42）项美国和外国专利申请，涉及其干细胞技术及其小分子化合物。","yearOnYearQuotes":[{"month":1,"riseRate":0.55,"avgChangeRate":0.003074},{"month":2,"riseRate":0.45,"avgChangeRate":-0.028546},{"month":3,"riseRate":0.473684,"avgChangeRate":0.009436},{"month":4,"riseRate":0.421053,"avgChangeRate":-0.042784},{"month":5,"riseRate":0.263158,"avgChangeRate":-0.085738},{"month":6,"riseRate":0.263158,"avgChangeRate":-0.050282},{"month":7,"riseRate":0.421053,"avgChangeRate":-0.087061},{"month":8,"riseRate":0.368421,"avgChangeRate":-0.088321},{"month":9,"riseRate":0.526316,"avgChangeRate":0.073462},{"month":10,"riseRate":0.210526,"avgChangeRate":-0.030579},{"month":11,"riseRate":0.421053,"avgChangeRate":-0.001568},{"month":12,"riseRate":0.473684,"avgChangeRate":0.019348}],"exchange":"NASDAQ","name":"Palisade Bio Inc.","nameEN":"Palisade Bio Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Palisade Bio Inc.(PALI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Palisade Bio Inc.(PALI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Palisade Bio Inc.,PALI,Palisade Bio Inc.股票,Palisade Bio Inc.股票老虎,Palisade Bio Inc.股票老虎国际,Palisade Bio Inc.行情,Palisade Bio Inc.股票行情,Palisade Bio Inc.股价,Palisade Bio Inc.股市,Palisade Bio Inc.股票价格,Palisade Bio Inc.股票交易,Palisade Bio Inc.股票购买,Palisade Bio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Palisade Bio Inc.(PALI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Palisade Bio Inc.(PALI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}